Survival, ventricular arrhythmia, and implantable cardioverter-defibrillator usefulness in toxic cardiomyopathy due to substance abuse.
Nicolas DogninGoran RimacGuillaume DomainAlexandre Cinq-MarsMontse MassotPierre Yves TurgeonSacha-Michelle Dubois-SénéchalChristine BourgaultJoëlle MorinMathieu BernierJonathan BeaudoinMaxime LaflammeEric CharbonneauCamille StrubéPierre VoisineFrançois PhilipponDavid BelzileMario SénéchalPublished in: Pacing and clinical electrophysiology : PACE (2023)
VA are infrequent in the T-DCM population. The prophylactic ICD benefit was not observed in our cohort. The ideal timing for potential prophylactic ICD implantation in this population needs further studies.